XML 41 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Investments in and Advances to Joint Ventures
12 Months Ended
Dec. 31, 2022
Equity Method Investments And Joint Ventures [Abstract]  
Investments in and Advances to Joint Ventures

16.

Investments in and Advances to Joint Ventures

The Company participates in joint ventures to bid, negotiate and complete specific projects. The Company is required to consolidate these joint ventures if it holds the majority voting interest or if the Company meets the criteria under the consolidation model, as described below.

The Company performs an analysis to determine whether its variable interests give the Company a controlling financial interest in a VIE for which the Company is the primary beneficiary and should, therefore, be consolidated. Such analysis requires the Company to assess whether it has the power to direct the activities of the VIE and the obligation to absorb losses or the right to receive benefits that could potentially be significant to the VIE.

The Company analyzed all of its joint ventures and classified them into two groups: (1) joint ventures that must be consolidated because they are either not VIEs and the Company holds the majority voting interest, or because they are VIEs and the Company is the primary beneficiary; and (2) joint ventures that do not need to be consolidated because they are either not VIEs and the Company holds a minority voting interest, or because they are VIEs and the Company is not the primary beneficiary.

Many of the Company’s joint venture agreements provide for capital calls to fund operations, as necessary; however, such funding is infrequent and is not anticipated to be material.

Letters of credit outstanding described in ‘Note 11—Debt and Credit Facilities” that relate to project ventures are approximately $106.8 million and $73.2 million at December 31, 2022 and December 31, 2021, respectively.

In the table below, aggregated financial information relating to the Company’s joint ventures is provided because their nature, risk and reward characteristics are similar. None of the Company’s current joint ventures that meet the characteristics of a VIE are individually significant to the consolidated financial statements.

Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements as of and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 (in thousands):

 

 

 

2022

 

 

2021

 

Current assets

 

$

289,837

 

 

$

246,342

 

Noncurrent assets

 

 

9,961

 

 

 

2,180

 

Total assets

 

 

299,798

 

 

 

248,522

 

Current liabilities

 

 

198,464

 

 

 

175,637

 

Total liabilities

 

 

198,464

 

 

 

175,637

 

Total joint venture equity

 

$

101,334

 

 

$

72,885

 

 

 

 

2022

 

 

2021

 

 

2020

 

Revenue

 

$

483,888

 

 

$

402,078

 

 

$

450,530

 

Costs

 

 

422,559

 

 

 

351,670

 

 

 

408,319

 

Net income

 

$

61,329

 

 

$

50,408

 

 

$

42,211

 

Net income attributable to noncontrolling interests

 

$

29,901

 

 

$

24,880

 

 

$

20,380

 

 

The assets of the consolidated joint ventures are restricted for use only by the particular joint venture and are not available for the Company’s general operations.

Unconsolidated Joint Ventures

The Company accounts for its unconsolidated joint ventures using the equity method of accounting. Under this method, the Company recognizes its proportionate share of the net earnings of these joint ventures as “Equity in earnings (loss) of unconsolidated joint ventures” in the consolidated statements of income. The Company’s maximum exposure to loss as a result of its investments in unconsolidated VIEs is typically limited to the aggregate of the carrying value of the investment and future funding commitments.

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements as of and for the years ended December 31, 2022 and December 31, 2021 (in thousands):

 

 

 

2022

 

 

2021

 

Current assets

 

$

1,610,246

 

 

$

1,620,735

 

Noncurrent assets

 

 

491,658

 

 

 

531,261

 

Total assets

 

 

2,101,904

 

 

 

2,151,996

 

Current liabilities

 

 

1,255,297

 

 

 

1,088,985

 

Noncurrent liabilities

 

 

468,056

 

 

 

669,911

 

Total liabilities

 

 

1,723,353

 

 

 

1,758,896

 

Total joint venture equity

 

$

378,551

 

 

$

393,100

 

Investments in and advances to unconsolidated joint

   ventures

 

$

107,425

 

 

$

110,688

 

 

 

 

2022

 

 

2021

 

 

2020

 

Revenue

 

$

2,406,407

 

 

$

2,709,305

 

 

$

1,830,802

 

Costs

 

 

2,325,472

 

 

 

2,536,403

 

 

 

1,709,933

 

Net income

 

$

80,935

 

 

$

172,902

 

 

$

120,869

 

Equity in earnings of unconsolidated joint ventures

 

$

16,347

 

 

$

36,862

 

 

$

30,059

 

 

 

The Company received net distribution from its unconsolidated joint ventures of $20.2 million and $30.5 million for the years ended December 31, 2022 and December 31, 2020, respectively, and had net contributions to its unconsolidated joint ventures of $13.2 million for the year ended December 31, 2021.    

 

For the years ended December 31, 2022, December 31, 2021 and December 31, 2020, the Company recorded a $13.8 million, $15.6 million and $15.5 million write-down, respectively, on an unconsolidated joint venture in the Critical Infrastructure segment as a result of changes in estimates made by the managing partner. For the year ended December 31, 2022, this write-down decreased operating and net income by $13.8 million and $10.3 million, respectively, and decreased diluted earnings per share by $0.09. For the year ended December 31, 2021, this write-down decreased operating and net income by $15.6 million and $11.6 million, respectively, and decreased diluted earnings per share by $0.10. For the year ended December 31, 2020, this write-down decreased operating and net income by $15.5 million and $11.5 million, respectively, and decreased diluted earnings per share by $0.11.